FIELD: medicine, ophthalmology.
SUBSTANCE: the present innovation deals with introducing a biological tissue into Tenon's space, moreover, it is necessary to apply a homotisue of cerebral white substance, it should be taken in a donor not later than 24 h after the onset of clinical lethal. The innovation is directed for the increase of sclerostrengthening effect of operation due to rapid development of fibrous tissue in area of ocular posterior pole in case of introducing bioactive material - homotissue of cerebral white substance.
EFFECT: higher efficiency of operation.
1 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
SCLERA-STRENGTHENING METHOD FOR TREATING THE CASES OF INFANTINE MYOPIA WITH HIGH RISK OF PROGRESSIVE DEVELOPMENT | 1999 |
|
RU2164111C2 |
BINARY ALLOTRANSPLANT APPLICABLE IN OPHTHALMIC SURGERY | 2001 |
|
RU2238703C2 |
METHOD FOR PREPARING SCLERAL ALLOGRAFT FOR SCLEROPLASTY IN PROGRESSIVE DEGENERATIVE MYOPIA | 2024 |
|
RU2822406C1 |
COMBINED SCLEROPLASTIC METHOD FOR TREATING THE CASES OF PROGRESSIVE MYOPIA WITH INHOMOGENEOUS SCLERA DEFORMITY | 2004 |
|
RU2271786C1 |
TRANSPLANT FOR PERFORMING SCLEROPLASTY | 1999 |
|
RU2161021C2 |
TRANSPLANT FOR CARRYING OUT SCLEROPLASTIC RAPID PROGRESSING MYOPIA TREATMENT | 2005 |
|
RU2297811C1 |
REINFORCED TRANSPLANT FOR SCLEROPLASTIC OPERATIONS | 1998 |
|
RU2140242C1 |
METHOD FOR TREATING THE CASES OF PROGRESSIVE AND AGGRAVATED MYOPIA | 2003 |
|
RU2238704C1 |
METHOD OF SURGICAL TREATMENT OF PROGRESSING AND COMPLICATED MYOPIA | 2012 |
|
RU2494711C1 |
IMPLANT FOR OPERATIONS ON IMPROVING HUMAN EYE COVERS | 2014 |
|
RU2579281C1 |
Authors
Dates
2006-12-10—Published
2005-02-16—Filed